123 related articles for article (PubMed ID: 19197461)
21. Imaging of frostbite injury by technetium-99m-sestamibi scintigraphy: a case report.
Aygit AC; Sarikaya A
Foot Ankle Int; 2002 Jan; 23(1):56-9. PubMed ID: 11822694
[TBL] [Abstract][Full Text] [Related]
22. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia.
Sahin M; Basoglu T; Albayrak S; Canbaz F; Yapici O
Clin Nucl Med; 2001 Jan; 26(1):62-4. PubMed ID: 11139060
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m sestamibi limb scintigraphy in post-traumatic reflex sympathetic dystrophy: preliminary results.
Sarikaya A; Sarikaya I; Pekindil G; Firat MF; Pekindil Y
Eur J Nucl Med; 2001 Oct; 28(10):1517-22. PubMed ID: 11685495
[TBL] [Abstract][Full Text] [Related]
24. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced osteomalacia: a case of diagnostic dilemma.
Robertson A; Mansberg R; Mansberg V; Van der Wall H; Hooper M
Clin Nucl Med; 2007 Aug; 32(8):631-4. PubMed ID: 17667438
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.
Jiang Y; Xia WB; Xing XP; Silva BC; Li M; Wang O; Zhang HB; Li F; Jing HL; Zhong DR; Jin J; Gao P; Zhou L; Qi F; Yu W; Bilezikian JP; Meng XW
J Bone Miner Res; 2012 Sep; 27(9):1967-75. PubMed ID: 22532501
[TBL] [Abstract][Full Text] [Related]
28. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.
Jin X; Jing H; Li F; Zhuang H
Clin Nucl Med; 2013 Nov; 38(11):922-4. PubMed ID: 24089059
[TBL] [Abstract][Full Text] [Related]
29. Increased Uptake of Brown Tumor in 99m Tc-HYNIC-TOC Scintigraphy Mimicking Postoperative Recurrence of Tumor-Induced Osteomalacia.
Zhang Y; Wang P; Liu M; Liu Y; Jing H
Clin Nucl Med; 2023 Nov; 48(11):978-979. PubMed ID: 37703478
[TBL] [Abstract][Full Text] [Related]
30. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
Ng DC; Sundram FX; Sin AE
J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic Osteomalacia: An Approach to Diagnosis with a Case Report.
Dey B; Gochhait D; Subramanian H; Ponnusamy M
J Clin Diagn Res; 2017 Apr; 11(4):ED05-ED07. PubMed ID: 28571152
[TBL] [Abstract][Full Text] [Related]
33. Tumor(s) induced osteomalacia--a curious case of double trouble.
Sahoo J; Balachandran K; Kamalanathan S; Das AK; Patro DK; Halanaik D; Badhe B
J Clin Endocrinol Metab; 2014 Feb; 99(2):395-8. PubMed ID: 24297794
[TBL] [Abstract][Full Text] [Related]
34. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Feb; 24(2):130-1. PubMed ID: 9988077
[No Abstract] [Full Text] [Related]
35. Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery.
Rubello D; Massaro A; Cittadin S; Rampin L; Al-Nahhas A; Boni G; Mariani G; Pelizzo MR
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1091-4. PubMed ID: 16804688
[TBL] [Abstract][Full Text] [Related]
36. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
Tsujimura T; Sakaguchi K; Aozasa K
Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
[TBL] [Abstract][Full Text] [Related]
37. Whole-body (99m)Tc-octreotide scintigraphy with SPECT/CT to detect occult tumor inducing paraneoplastic osteomalacia.
Rodrigues NR; Calich AL; Etchebehere M; Ichiki WA; Pereira FP; Amstalden EM; de Sa Etchebehere EC
Clin Nucl Med; 2015 Jan; 40(1):54-7. PubMed ID: 24458181
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
39. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
40. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
